Literature DB >> 25784151

Bioorthogonal deprotection on the dendritic cell surface for chemical control of antigen cross-presentation.

Joanna B Pawlak1, Geoffroy P P Gential, Tracy J Ruckwardt, Jessica S Bremmers, Nico J Meeuwenoord, Ferry A Ossendorp, Herman S Overkleeft, Dmitri V Filippov, Sander I van Kasteren.   

Abstract

The activation of CD8(+) T-cells requires the uptake of exogenous polypeptide antigens and proteolytic processing of these antigens to octamer or nonamer peptides, which are loaded on MHC-I complexes and presented to the T-cell. By using an azide as a bioorthogonal protecting group rather than as a ligation handle, masked antigens were generated-antigens that are not recognized by their cognate T-cell unless they are deprotected on the cell using a Staudinger reduction.
© 2015 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  Staudinger reduction; antigens; azides; bioorthogonal chemistry; cell recognition

Mesh:

Substances:

Year:  2015        PMID: 25784151     DOI: 10.1002/anie.201500301

Source DB:  PubMed          Journal:  Angew Chem Int Ed Engl        ISSN: 1433-7851            Impact factor:   15.336


  12 in total

Review 1.  Development and application of bond cleavage reactions in bioorthogonal chemistry.

Authors:  Jie Li; Peng R Chen
Journal:  Nat Chem Biol       Date:  2016-03       Impact factor: 15.040

2.  Bioorthogonal Click and Release: A General, Rapid, Chemically Revertible Bioconjugation Strategy Employing Enamine N-oxides.

Authors:  Dahye Kang; Sanghyeon Lee; Justin Kim
Journal:  Chem       Date:  2022-06-15       Impact factor: 25.832

3.  Light Guided In-vivo Activation of Innate Immune Cells with Photocaged TLR 2/6 Agonist.

Authors:  Keun Ah Ryu; Bethany McGonnigal; Troy Moore; Tawnya Kargupta; Rock J Mancini; Aaron P Esser-Kahn
Journal:  Sci Rep       Date:  2017-08-14       Impact factor: 4.379

4.  Detection of bioorthogonal groups by correlative light and electron microscopy allows imaging of degraded bacteria in phagocytes.

Authors:  Daphne M van Elsland; Erik Bos; Wouter de Boer; Herman S Overkleeft; Abraham J Koster; Sander I van Kasteren
Journal:  Chem Sci       Date:  2015-10-23       Impact factor: 9.825

5.  Targeted Diazotransfer Reagents Enable Selective Modification of Proteins with Azides.

Authors:  Jonas Lohse; Lotteke J Y M Swier; Ruben C Oudshoorn; Guillaume Médard; Bernhard Kuster; Dirk-Jan Slotboom; Martin D Witte
Journal:  Bioconjug Chem       Date:  2017-04-05       Impact factor: 4.774

Review 6.  Site-Selective Disulfide Modification of Proteins: Expanding Diversity beyond the Proteome.

Authors:  Seah Ling Kuan; Tao Wang; Tanja Weil
Journal:  Chemistry       Date:  2016-10-25       Impact factor: 5.236

7.  Chemical Control over T-Cell Activation in Vivo Using Deprotection of trans-Cyclooctene-Modified Epitopes.

Authors:  Anouk M F van der Gracht; Mark A R de Geus; Marcel G M Camps; Tracy J Ruckwardt; Alexi J C Sarris; Jessica Bremmers; Elmer Maurits; Joanna B Pawlak; Michelle M Posthoorn; Kimberly M Bonger; Dmitri V Filippov; Herman S Overkleeft; Marc S Robillard; Ferry Ossendorp; Sander I van Kasteren
Journal:  ACS Chem Biol       Date:  2018-05-11       Impact factor: 5.100

8.  Amyloid-like Behavior of Site-Specifically Citrullinated Myelin Oligodendrocyte Protein (MOG) Peptide Fragments inside EBV-Infected B-Cells Influences Their Cytotoxicity and Autoimmunogenicity.

Authors:  Can Araman; Miriam E van Gent; Nico J Meeuwenoord; Nicole Heijmans; Mikkel H S Marqvorsen; Ward Doelman; Bart W Faber; Bert A 't Hart; Sander I Van Kasteren
Journal:  Biochemistry       Date:  2019-01-14       Impact factor: 3.162

9.  Bioorthogonal Chemical Activation of Kinases in Living Systems.

Authors:  Gong Zhang; Jie Li; Ran Xie; Xinyuan Fan; Yanjun Liu; Siqi Zheng; Yun Ge; Peng R Chen
Journal:  ACS Cent Sci       Date:  2016-04-27       Impact factor: 14.553

Review 10.  Approaches to Improve Chemically Defined Synthetic Peptide Vaccines.

Authors:  Brett J Hos; Elena Tondini; Sander I van Kasteren; Ferry Ossendorp
Journal:  Front Immunol       Date:  2018-04-26       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.